609A

· Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 609A, covering 2022-01-14 to 2022-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma [Phase 2]